Clinical Trials Sponsored by Daiwa Pharmaceutical Corporation Co, Ltd, Tokyo 154-0024 Japan

Total 2 results

Cairo University
University of California, Los Angeles; Daiwa Pharmaceutical Corporation Co,...

Completed

Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV

Hepatitis C, Chronic
Zagazig University
University of California, Irvine; Charles Drew University of Medicine and Science and other collaborators

Completed

Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses

Influenza-like Illness

Egypt

3

Subscribe